Differential Survival of Leukocyte Subsets Mediated by Synovial, Bone Marrow, and Skin Fibroblasts: Site-specific Versus Activation-dependent Survival of T Cells and Neutrophils
Overview
Authors
Affiliations
Objective: Synovial fibroblasts share a number of phenotype markers with fibroblasts derived from bone marrow. In this study we investigated the role of matched fibroblasts obtained from 3 different sources (bone marrow, synovium, and skin) to test the hypothesis that synovial fibroblasts share similarities with bone marrow-derived fibroblasts in terms of their ability to support survival of T cells and neutrophils.
Methods: Matched synovial, bone marrow, and skin fibroblasts were established from 8 different patients with rheumatoid arthritis who were undergoing knee or hip surgery. Resting or activated fibroblasts were cocultured with either CD4 T cells or neutrophils, and the degree of leukocyte survival, apoptosis, and proliferation were measured.
Results: Fibroblasts derived from all 3 sites supported increased survival of CD4 T cells, mediated principally by interferon-beta. However, synovial and bone marrow fibroblasts shared an enhanced site-specific ability to maintain CD4 T cell survival in the absence of proliferation, an effect that was independent of fibroblast activation or proliferation but required direct T cell-fibroblast cell contact. In contrast, fibroblast-mediated neutrophil survival was less efficient, being independent of the site of origin of the fibroblast but dependent on prior fibroblast activation, and mediated solely by soluble factors, principally granulocyte-macrophage colony-stimulating factor.
Conclusion: These results suggest an important functional role for fibroblasts in the differential accumulation of leukocyte subsets in a variety of tissue microenvironments. The findings also provide a potential explanation for site-specific differences in the pattern of T cell and neutrophil accumulation observed in chronic inflammatory diseases.
Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis.
Qian H, Deng C, Chen S, Zhang X, He Y, Lan J Arthritis Res Ther. 2024; 26(1):103.
PMID: 38783357 PMC: 11112866. DOI: 10.1186/s13075-024-03343-4.
Rohini S, Sharma U, Vinutha M, Shreelaxmi D, Vada S, Janandri S Inflammopharmacology. 2024; 32(4):1-17.
PMID: 38691248 DOI: 10.1007/s10787-024-01482-3.
Barron A, Fabre T, De S F1000Res. 2024; 13:54.
PMID: 38681509 PMC: 11053351. DOI: 10.12688/f1000research.143472.1.
Cheng Y, Ji Y, Feng K, Zhang X, Xiao Y, Jing W Exp Ther Med. 2024; 27(5):212.
PMID: 38590567 PMC: 11000449. DOI: 10.3892/etm.2024.12499.
Panja S, Benjamin J, Paria B Int J Mol Sci. 2021; 22(15).
PMID: 34360700 PMC: 8347248. DOI: 10.3390/ijms22157932.